Borrowing From the Cancer Playbook to Find Treatment for Alzheimer's Disease
CNN recently featured Doug Williamson, MD, Lundbeck's Chief Medical Officer and Vice President, US Medical, in an article on groundbreaking new approaches to Alzheimer's treatments. The piece highlighted Lundbeck's work with partner ImmunoBrain Checkpoint. The collaboration is exploring how immune checkpoint inhibitors, a type of cancer drug that is often made of antibodies able to trigger an immune response and "turn off" the ability of cancer cells to masquerade as normal, could be used against Alzheimer's disease.
Read the full article here.